(SGNT) (SGNT) Stock Price, News & Analysis

Company Overview

Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.

Key Stats

• Today's Range: $21.76 to $21.76
• 50-Day Range: N/A
• 52-Week Range: $10.55 to $21.88
• Volume: N/A
• Average Volume: 607,514 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SGNT Stock Analysis - Frequently Asked Questions

How were (SGNT)'s earnings last quarter?

(SGNT) (NASDAQ:SGNT) posted its earnings results on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.05 by $0.06. The company's revenue was up 11.7% on a year-over-year basis.

What other stocks do shareholders of (SGNT) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (SGNT) investors own include Mazor Robotics (MZOR), SELLAS Life Sciences Group (SLS), Allena Pharmaceuticals (ALNA), Advanced Micro Devices (AMD), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC) and Idera Pharmaceuticals (IDRA).

Company Calendar

• Last Earnings: 8/04/2015
• Today: 7/01/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:SGNT
• CIK: 1369786
• Web: www.sagentpharma.com
• Phone: +1-847-9081604
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A